Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

31.99 -0.15 (-0.47%)

Streaming Delayed Price Updated: 2:07 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

29 30 Next >

Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment? ↗

June 30, 2025

The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide.

Via Investor's Business Daily

3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking

June 29, 2025

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

Via MarketBeat

Topics Artificial Intelligence Economy

Why This Weight Loss Drug Company's Stock Surged Today ↗

June 26, 2025

Via The Motley Fool

3 Growth Stocks I'm Loading Up On ↗

June 26, 2025

Via The Motley Fool

Topics Artificial Intelligence Government

Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity ↗

June 25, 2025

The company just initiated two Phase 3 studies of its weekly under-the-skin shot to stoke weight loss.

Via Investor's Business Daily

What's Going On With Viking Therapeutics Stock On Wednesday? ↗

June 25, 2025

Viking Therapeutics begins Phase 3 trials for VK2735, testing weekly injections in over 5,000 adults with obesity or type 2 diabetes over 78 weeks.

Via Benzinga

My 5 Favorite Dirt Cheap Stocks to Buy Right Now ↗

June 24, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy World Trade

Amgen Expands Development Plans For Highly Anticipated Obesity Drug ↗

June 23, 2025

Amgen is expanding its plans for weight-loss drug, MariTide, with a trio of upcoming Phase 3 studies.

Via Investor's Business Daily

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts ↗

June 21, 2025

Via The Motley Fool

Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside. ↗

June 18, 2025

Via The Motley Fool

Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks? ↗

June 16, 2025

Via The Motley Fool

Topics Government

10 Health Care Stocks Whale Activity In Today's Session ↗

June 10, 2025

Via Benzinga

1 Stock Down 34% This Year to Buy and Hold ↗

June 08, 2025

Via The Motley Fool

Could Viking Therapeutics Become the Next Eli Lilly? ↗

June 02, 2025

Via The Motley Fool

3 Best Growth Stocks to Buy in June ↗

June 02, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy Government

Better Weight Loss Stock: Amgen or Viking Therapeutics? ↗

May 22, 2025

Via The Motley Fool

Why Viking Therapeutics Stock Bumped 3% Higher Today ↗

May 16, 2025

Via The Motley Fool

Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price ↗

May 16, 2025

Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition.

Via Investor's Business Daily

Why Weight-Loss Developer Stocks Tumbled on Tuesday ↗

May 13, 2025

Via The Motley Fool

Topics Government

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years ↗

May 13, 2025

Via The Motley Fool

3 Monster Stocks in the Making ↗

May 11, 2025

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 09, 2025

Via Benzinga

Down Nearly 20%: Should You Buy the Dip on Eli Lilly? ↗

May 08, 2025

Via The Motley Fool

Topics Earnings Government World Trade

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April ↗

May 06, 2025

Via The Motley Fool

Why Viking Therapeutics Stock Was Victorious This Week ↗

May 02, 2025

Via The Motley Fool

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday ↗

May 02, 2025

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock investors.

Via The Motley Fool

Topics World Trade

Is Novo Nordisk Stock a Buy? ↗

May 02, 2025

Via The Motley Fool

Where Will Viking Therapeutics Be in 3 Years? ↗

May 02, 2025

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.

Via The Motley Fool

Topics Bankruptcy

1 Beaten-Down Stock to Buy and Hold for 10 Years ↗

May 01, 2025

Via The Motley Fool

Topics Economy

Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? ↗

April 30, 2025

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.